308 related articles for article (PubMed ID: 27203153)
21. Cognitive functioning in patients with cerebral aneurysms measured with the mini mental state examination and the telephone interview for cognitive status.
King JT; DiLuna ML; Cicchetti DV; Tsevat J; Roberts MS
Neurosurgery; 2006 Oct; 59(4):803-10; discussion 810-1. PubMed ID: 17038944
[TBL] [Abstract][Full Text] [Related]
22. Processing speed differences between schizophrenia and schizoaffective disorder: A pilot study.
Mondragón-Maya A; Flores-Medina Y; Ramos-Mastache D; Vales MR; Olivares Neumann JL; Escamilla-Orozco R; Saracco-Álvarez R
Psychiatr Danub; 2019 Sep; 31(3):355-357. PubMed ID: 31596829
[TBL] [Abstract][Full Text] [Related]
23. Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable?
Heinrichs RW; Ammari N; McDermid Vaz S; Miles AA
Schizophr Res; 2008 Feb; 99(1-3):149-54. PubMed ID: 18031992
[TBL] [Abstract][Full Text] [Related]
24. Cognitive functioning and age at onset in non-affective psychotic disorder.
van der Werf M; Köhler S; Verkaaik M; Verhey F; van Os J;
Acta Psychiatr Scand; 2012 Oct; 126(4):274-81. PubMed ID: 22582732
[TBL] [Abstract][Full Text] [Related]
25. Cognitive impairments in schizophrenia and schizoaffective disorder: relationship with clinical characteristics.
Torniainen M; Suvisaari J; Partonen T; Castaneda AE; Kuha A; Suokas J; Perälä J; Saarni SI; Lönnqvist J; Tuulio-Henriksson A
J Nerv Ment Dis; 2012 Apr; 200(4):316-22. PubMed ID: 22456585
[TBL] [Abstract][Full Text] [Related]
26. Identification of clinically meaningful relationships among cognition, functionality, and symptoms in subjects with schizophrenia or schizoaffective disorder.
Pandina G; Bilder R; Turkoz I; Alphs L
Schizophr Res; 2013 Feb; 143(2-3):312-8. PubMed ID: 23276482
[TBL] [Abstract][Full Text] [Related]
27. A new computerized cognitive and social cognition training specifically designed for patients with schizophrenia/schizoaffective disorder in early stages of illness: A pilot study.
Fernandez-Gonzalo S; Turon M; Jodar M; Pousa E; Hernandez Rambla C; García R; Palao D
Psychiatry Res; 2015 Aug; 228(3):501-9. PubMed ID: 26163731
[TBL] [Abstract][Full Text] [Related]
28. Paranoid Schizophrenia versus Schizoaffective Disorder: Neuropsychological Aspects.
Leposavić L; Leposavić I; Šaula-Marojević B; Gavrilović P
Srp Arh Celok Lek; 2015; 143(7-8):391-6. PubMed ID: 26506747
[TBL] [Abstract][Full Text] [Related]
29. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
[TBL] [Abstract][Full Text] [Related]
30. [Psychometric differentiation of schizophrenic and schizoaffective psychoses].
Bühler KE; Gross M; Jürgensen R
Schweiz Arch Neurol Psychiatr (1985); 1991; 142(6):535-52. PubMed ID: 1722906
[TBL] [Abstract][Full Text] [Related]
31. Mild cognitive impairment in medical inpatients: the Mini-Mental State Examination is a promising screening tool.
De Marchis GM; Foderaro G; Jemora J; Zanchi F; Altobianchi A; Biglia E; Conti FM; Monotti R; Mombelli G
Dement Geriatr Cogn Disord; 2010; 29(3):259-64. PubMed ID: 20375507
[TBL] [Abstract][Full Text] [Related]
32. The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients.
Walterfang M; Siu R; Velakoulis D
Aust N Z J Psychiatry; 2006; 40(11-12):995-1002. PubMed ID: 17054568
[TBL] [Abstract][Full Text] [Related]
33. Correlates of health-related quality of well-being in older patients with schizophrenia.
Mittal D; Davis CE; Depp C; Pyne JM; Golshan S; Patterson TL; Jeste DV
J Nerv Ment Dis; 2006 May; 194(5):335-40. PubMed ID: 16699382
[TBL] [Abstract][Full Text] [Related]
34. A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors.
Dickerson F; Schroeder J; Stallings C; Origoni A; Katsafanas E; Schwienfurth LA; Savage CL; Khushalani S; Yolken R
Schizophr Res; 2014 Jul; 156(2-3):248-53. PubMed ID: 24827555
[TBL] [Abstract][Full Text] [Related]
35. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
[TBL] [Abstract][Full Text] [Related]
36. Correlation between age and MMSE in schizophrenia.
Maltais JR; Gagnon G; Garant MP; Trudel JF
Int Psychogeriatr; 2015 Nov; 27(11):1769-75. PubMed ID: 25872525
[TBL] [Abstract][Full Text] [Related]
37. Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia?
Linke M; Jankowski KS; Ciołkiewicz A; Jędrasik-Styła M; Parnowska D; Gruszka A; Denisiuk M; Jarema M; Wichniak A
Psychiatry Res; 2015 Jan; 225(1-2):197-201. PubMed ID: 25482394
[TBL] [Abstract][Full Text] [Related]
38. A study of bedside screening procedures for cognitive deficits in chronic psychiatric inpatients.
de Leon J; Pearlman O; Doonan R; Simpson GM
Compr Psychiatry; 1996; 37(5):328-35. PubMed ID: 8879907
[TBL] [Abstract][Full Text] [Related]
39. Insight dimensions and cognitive function in psychosis: a longitudinal study.
Cuesta MJ; Peralta V; Zarzuela A; Zandio M
BMC Psychiatry; 2006 May; 6():26. PubMed ID: 16737523
[TBL] [Abstract][Full Text] [Related]
40. The role of neurocognitive deficits in understanding adaptive functioning in severe psychiatric illness: commentary on Hawkins and Cooper.
Nuechterlein KH; Subotnik KL
Psychiatry; 1996; 59(4):389-92. PubMed ID: 9029660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]